Nuveen Dividend Value Fund Class R6 (FFEFX)
Fund Assets | 1.19B |
Expense Ratio | 0.61% |
Min. Investment | $1,000,000 |
Turnover | n/a |
Dividend (ttm) | 1.56 |
Dividend Yield | 11.34% |
Dividend Growth | 105.49% |
Payout Frequency | Quarterly |
Ex-Dividend Date | Mar 31, 2025 |
Previous Close | 13.37 |
YTD Return | -9.04% |
1-Year Return | -4.33% |
5-Year Return | 69.21% |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | n/a |
Holdings | 75 |
Inception Date | Feb 28, 2013 |
About FFEFX
The Fund's investment strategy focuses on Equity Income with 0.7% total expense ratio. The minimum amount to invest in Nuveen Investment Funds, Inc: Nuveen Dividend Value Fund; Class R6 Shares is $1,000,000 on a standard taxable account. Nuveen Investment Funds, Inc: Nuveen Dividend Value Fund; Class R6 Shares seeks long-term growth of capital and income. FFEFX invests at least 80% of its net assets in equity securities. FFEFXs sub-adviser will invest in companies that it believes have the ability to pay above average dividends and finance expected growth and are trading at attractive valuations.
Performance
FFEFX had a total return of -4.33% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.78%.
Top 10 Holdings
24.61% of assetsName | Symbol | Weight |
---|---|---|
Philip Morris International Inc. | PM | 3.17% |
UnitedHealth Group Incorporated | UNH | 3.02% |
Wells Fargo & Company | WFC | 2.76% |
AT&T Inc. | T | 2.52% |
Citigroup Inc. | C | 2.50% |
The Cigna Group | CI | 2.27% |
Abbott Laboratories | ABT | 2.17% |
The Southern Company | SO | 2.13% |
NextEra Energy, Inc. | NEE | 2.03% |
Bristol-Myers Squibb Company | BMY | 2.03% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Mar 31, 2025 | $0.0594 | Apr 1, 2025 |
Dec 30, 2024 | $0.058 | Dec 31, 2024 |
Dec 16, 2024 | $1.3153 | Dec 17, 2024 |
Sep 30, 2024 | $0.0639 | Oct 1, 2024 |
Jun 28, 2024 | $0.061 | Jul 1, 2024 |
Mar 28, 2024 | $0.0597 | Apr 1, 2024 |